Skyline Ventures

Entry	Author	Date	Location
Sutro Biopharma Pulls in $16M for New Antibody Drugs	Luke Timmerman	05/08/12	San Francisco
Sutro Biopharma Lands $16,500,000 Series C Funding	VentureDeal	05/08/12	San Francisco
Collegium Pharmaceutical Receives $22,500,000 New Funding Round	VentureDeal	02/22/12	Boston
Tolerx Shutters, Courtagen Gets $8M, OvaScience Emerges, & More Boston-Area Life Sciences News	Erin Kutz	10/14/11	Boston
Report: Tolerx Folds Its Tent, After $150M in Investment and a Failed Diabetes Drug Trial	Luke Timmerman	10/07/11	Boston
SI-Bone Secures $16,000,000 New Financing Round	VentureDeal	09/26/11	San Francisco
Tolerx and Glaxo Diabetes Drug Disappoints in Late-Stage Study	Ryan McBride	03/11/11	Boston
AcelRx Prices IPO	Wade Roush	01/21/11	San Francisco
Longwood Raises First Fund, Biogen Adds Executives, Boston Scientific Acquires Intellect, & More Boston-Area Life Sciences News	Erin Kutz	01/07/11	Boston
SCVNGR Scares Up $15M, Genocea Gets $35M, Zeo Zeros in on $12.3M, & More Boston-Area Deals News	Rebecca Zacks	01/05/11	Boston
Genocea Biosciences Raises $35M from J&J and Others for Vaccines Business	Ryan McBride	01/03/11	Boston
Genocea Biosciences Obtains $35,000,000 Series B Funding Round	VentureDeal	01/03/11	Boston
How Michael French, a Military Brat Turned Dealmaker, Kept Marina Biotech Alive	Luke Timmerman	12/20/10	Seattle
Sutro Biopharma Grabs $36.5M in Venture Deal to Make “Biobetters”	Luke Timmerman	11/17/10	San Francisco
Sutro Biopharma Secures $36,500,000 Series C Round	VentureDeal	11/17/10	San Francisco
Dicerna Gets Glaxo’s SR One to Join Investor Syndicate	Ryan McBride	10/21/10	Boston
Sequel Raises $1.4M	Bruce V. Bigelow	09/09/10	San Diego
SI-Bone Raises $11M	Wade Roush	08/18/10	San Francisco
IBM Buys Unica, A123 Spinout Raises $10M, Zynga Acquires Conduit, & More Boston-Area Deals News	Erin Kutz	08/18/10	Boston
SI-Bone Lands $11,000,000 New Funding Round	VentureDeal	08/18/10	San Francisco
Former Sirtris Execs Sell Resveratrol Via New Nonprofit, Dicerna Closes $25M Deal, ViThera Combats Gut Disease With Engineered Bacteria, & More Boston-Area Life Sciences News	Rebecca Zacks	08/13/10	Boston
Dicerna Pharma Gets $25M Boost to Develop Next-Gen Gene Silencing Drugs	Ryan McBride	08/11/10	Boston
Dicerna Pharmaceuticals Garners $25,000,000 Series B Funding	VentureDeal	08/11/10	Boston
CEO Eric Meier Out at Calypso Medical; Layoffs Reported	Thea Chard	08/06/10	Seattle
Biogen Names CEO, Glaser Leaves Partners, SV Closes $523M Fund, & More Boston-Area Life Sciences News	Erin Kutz	07/02/10	Boston
$5M Debt Deal for Dicerna Pharma	Ryan McBride	06/30/10	Boston
Zipcar Files for $75M IPO, Tetraphase Gets $45M, Covidien Acquires ev3 for $2.6B, & More Boston-Area Deals News	Erin Kutz	06/02/10	Boston
TetraPhase Pharmaceuticals Receives $45,000,000 Series C Financing	VentureDeal	06/01/10	Boston
Halozyme Announces Recall, Pathway Genomics Halts Genetic Test Kit Rollout, Vertex Gets Ready for Hepatitis C Results, & More San Diego Life Sciences News	Bruce V. Bigelow	05/20/10	San Diego
Celula Receives $15,000,000 Series B Round	VentureDeal	05/19/10	San Diego
Page 1 of 3	next page »

Entry

Author

Date

Location

Sutro Biopharma Pulls in $16M for New Antibody Drugs

Luke Timmerman

05/08/12

San Francisco

Sutro Biopharma Lands $16,500,000 Series C Funding

VentureDeal

05/08/12

San Francisco